Xembify® (immune globulin subcutaneous, human – klhw)
for Primary Immunodeficiency Disorder
Xembify (immune globulin subcutaneous, human-klhw) is a ready-to-use solution containing immunoglobulin G (IgG) antibodies, used to protect patients aged 2 and older with primary humoral immunodeficiencies (PI) against infections. It treats conditions like congenital agammaglobulinemia, common variable immunodeficiency, and Wiskott-Aldrich syndrome. Administered as a subcutaneous infusion, Xembify provides a broad spectrum of IgG antibodies to fight infections and regulate immune system activity.